arrow
C

C. Gaujoux-Viala

University of Montpellier
H指数:28
被引数:8,877

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Methotrexate Maintenance After Initiation of Biological or Targeted Synthetic DMARDs in Rheumatoid Arthritis: Results from the 2-Year Longitudinal Prospective Non-interventional STRATEGE2 Study

甲氨蝶呤在生物制剂或合成靶向DMARDs开始使用后的维持治疗:来自2年纵向前瞻性非干预性STRATEGE2研究的结果

2025-12-030
OAAI
Effect of a 1-month methotrexate delay on pneumococcal vaccine immunogenicity and disease control in patients with early rheumatoid arthritis (VACIMRA): an open-label randomised trial

早期类风湿关节炎患者中1个月甲氨蝶呤延迟对肺炎球菌疫苗免疫原性和疾病控制的影响(VACIMRA):一项开放标签随机试验

2025-07-290
PRE
French recommendations for assessing and managing the risk of cancer before the initiation of targeted therapies for chronic rheumatic inflammatory diseases

法国关于在慢性风湿性炎症疾病靶向治疗开始前评估和管理癌症风险的建议

2025-07-120
OA
Early peripheral psoriatic arthritis: Baseline features of the first 186 patients in the French Nationwide APACHE Cohort

早期外周型银屑病关节炎:法国全国性APACHE队列中前186例患者的基线特征

2025-05-270
OA
2024 update of the recommendations of the French Society of Rheumatology for the diagnosis and management of patients with rheumatoid arthritis

2024年法国风湿病学学会类风湿关节炎诊断与治疗建议更新

2024-12-011
PRE
Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients

疾病活动和广泛的疼痛是中轴型脊柱关节炎患者报告的全球健康的主要因素: 对6064名患者的分析

2024-04-105
PRE
Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open-Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission
2024-01-251
OAAI